Aducanumab: What About the Patient?; Risk of Aneurysm Rupture After Stroke Thrombolysis
Release Date: 11/01/2021
Features of Educational Social Media Posts
Neurology® Podcast
Dr. Stacey Clardy talks with Dr. Catherine Albin about the key features of educational social media posts, strategies for creating impactful content, the importance of visual appeal, and the role of community engagement in neurology education. Read the related article in . Disclosures can be found at .
info_outline
Long-Term Outcomes and Rehabilitation in Anti-NMDAR Encephalitis
Neurology® Podcast
Dr. Justin Abbatemarco talks with Dr. Maarten Titulaer about long-term cognitive and functional outcomes in patients with anti-NMDAR encephalitis and their implications for rehabilitation. Read the related article in . Disclosures can be found at .
info_outline
Myelitis Associated With Rheumatologic Disease
Neurology® Podcast
Dr. Stacey Clardy talks with Dr. Elias Sotirchos about the underlying etiologies of myelitis in patients with rheumatologic disease. Read the related article in . Disclosures can be found at Neurology.org.
info_outline
The Placebo Effect
Neurology® Podcast
Dr. Gregg Day talks with Dr. Kathryn T. Hall about the complexities of the placebo effect, its variability among patients, and the genetic factors that influence responses to placebo treatments. Disclosures can be found at .
info_outline
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS
Neurology® Podcast
Dr. Justin Abbatemarco talks with Dr. Ahmad Nehme about the complexities of diagnosing and differentiating between cerebral amyloid angiopathy-related inflammation and biopsy-positive primary angiitis of the central nervous system. Read the related article in . Disclosures can be found at .
info_outline
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 2
Neurology® Podcast
In the concluding segment of this two-part series, Dr. Justin Abbatemarco talks with Dr. Jennifer L. Orthmann-Murphy about genetic leukodystrophies and the increasing recognition of these disorders in adult neurology, the importance of genetic testing, and the evolving treatment landscape. Read the related articles in and . Disclosures can be found at Neurology.org.
info_outline
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 1
Neurology® Podcast
In the first part of this two-part series, Dr. Justin Abbatemarco talks with Dr. Jennifer L. Orthmann-Murphy about a practical approach to genetic leukodystrophies, focusing on the importance of genetic testing, identifying red flags in patients, and navigating the complexities of hereditary spastic paraplegia. Read the related articles in and . Disclosures can be found at .
info_outline
November 2024 Recall: Topics of Brain Health
Neurology® Podcast
The November 2024 replay features four episodes dedicated to brain health. It kicks off with an interview with Dr. Nicoline Schiess, who discusses the World Health Organization (WHO) Brain Health Unit. Next, Dr. Katrin Seeher delves into the global burden of neurological conditions and the WHO’s strategies to enhance care and awareness. The third segment features Dr. Natalia Rost who introduces and highlights the American Academy of Neurology’s (AAN) groundbreaking brain health initiative. The episode wraps up with Dr. Rost again, who returns to give an update and emphasize the urgency of...
info_outline
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders
Neurology® Podcast
Dr. Justin Abbatemarco talks with Drs. Marius Ringelstein and Ilya Ayzenberg about the effectiveness and safety of Eculizumab in routine clinical care. Read the related article in . Disclosures can be found at .
info_outline
Interventions for the Acute Management of Migraine Episodes in Adults
Neurology® Podcast
Dr. Tesha Monteith talks with Drs. Messoud Ashina and Andrea Cipriani about all licensed drug interventions as oral monotherapy for the acute treatment of migraine episodes in adults. Read the related article in . Disclosures can be found at .
info_outlineIn the first part of the podcast, Dr. Gregg Day discusses the importance of patient participation in the decision-making process when considering the use of aducanumab for the treatment of Alzheimer disease with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer’s Disease Center. In the second segment, Dr. Andy Southerland talks with Dr. Jyri Virta about the risk of aneurysm rupture after thrombolysis in patients with acute ischemic stroke and unruptured intracranial aneurysms.